“INVESTIGATIONS ON CLINICAL VALIDATION OF MUTATED ZNF208 AS A NOVEL BIOMARKER OF BLAST CRISIS IN CHRONIC MYELOID LEUKEMIA”. Journal of Population Therapeutics and Clinical Pharmacology 31, no. 9 (September 20, 2024): 1502–1518. Accessed September 28, 2024. https://jptcp.com/index.php/jptcp/article/view/7959.